Rapid Communication |
From the Departments of Molecular and Cellular Physiology (R.L.S., E.G.K., R.J.P.); Pharmacology and Cell Biophysics (V.J.K., R.J.P.); Molecular Genetics (J.B.H.), University of Cincinnati College of Medicine, Cincinnati, Ohio.
Correspondence to Richard J. Paul, PhD, PO Box 670576, 231 Bethesda Ave, Cincinnati, OH 45267-0576. E-mail Richard.Paul{at}uc.edu
AbstractVascular endothelial cells regulate vascular smooth muscle tone through Ca2+-dependent production and release of vasoactive molecules. Phospholamban (PLB) is a 24- to 27-kDa phosphoprotein that modulates activity of the sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA). Expression of PLB is reportedly limited to cardiac, slow-twitch skeletal and smooth muscle in which PLB is an important regulator of [Ca2+]i and contractility in these muscles. In the present study, we report the existence of PLB in the vascular endothelium, a nonmuscle tissue, and provide functional data on PLB regulation of vascular contractility through its actions in the endothelium. Endothelium-dependent relaxation to acetylcholine was attenuated in aorta of PLB-deficient (PLB-KO) mice compared with wild-type (WT) controls. This effect was not due to actions of nitric oxide on the smooth muscle, because sodium nitroprussidemediated relaxation in either denuded or endothelium-intact aortas was unaffected by PLB ablation. Relative to denuded vessels, relaxation to forskolin was enhanced in WT endothelium-intact aortas. The endothelium-dependent component of this relaxation was attenuated in PLB-KO aortas. To investigate whether these changes were due to PLB, WT mouse aorta endothelial cells were isolated. Both reverse transcriptasepolymerase chain reaction and Western blot analyses revealed the presence of PLB in endothelial cells, which were shown to be >98% pure by diI-acetylated LDL uptake and nuclear counterstaining. These data indicate that PLB is present and modulates vascular function as a result of its actions in endothelial cells. The presence of PLB in endothelial cells opens new fields for investigation of Ca2+ regulatory pathways in nonmuscle cells and for modulation of endothelial-vascular interactions.
Key Words: phospholamban endothelium vasorelaxation SERCA Ca2+
This article has been cited by other articles:
![]() |
H. Taniguchi, I. Mohri, H. Okabe-Arahori, K. Aritake, K. Wada, T. Kanekiyo, S. Narumiya, M. Nakayama, K. Ozono, Y. Urade, et al. Prostaglandin D2 Protects Neonatal Mouse Brain from Hypoxic Ischemic Injury J. Neurosci., April 18, 2007; 27(16): 4303 - 4312. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kim and B. A. Perrino CaM kinase II activation and phospholamban phosphorylation by SNP in murine gastric antrum smooth muscles Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1045 - G1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Carr, B. W. Howard, H. T. Yang, E. Eby-Wilkens, P. Loos, A. Varbanov, A. Qu, J. P. DeMuth, M. G. Davis, A. Proia, et al. Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: Support for an endothelium-dependent mechanism Cardiovasc Res, March 1, 2006; 69(4): 925 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F Frank, B. Bolck, E. Erdmann, and R. H.G Schwinger Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation Cardiovasc Res, January 1, 2003; 57(1): 20 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pollesello and A. Annila Structure of the 1-36 N-Terminal Fragment of Human Phospholamban Phosphorylated at Ser-16 and Thr-17 Biophys. J., July 1, 2002; 83(1): 484 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Knapp, P. Bokník, B. Linck, H. Lüss, F. U. Müller, L. Petertönjes, W. Schmitz, and J. Neumann Cantharidin Enhances Norepinephrine-Induced Vasoconstriction in an Endothelium-Dependent Fashion J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 620 - 626. [Abstract] [Full Text] |
||||
![]() |
S. Rao and A. S. Verkman Analysis of organ physiology in transgenic mice Am J Physiol Cell Physiol, July 1, 2000; 279(1): C1 - C18. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Brittsan, A. N. Carr, A. G. Schmidt, and E. G. Kranias Maximal Inhibition of SERCA2 Ca2+ Affinity by Phospholamban in Transgenic Hearts Overexpressing a Non-phosphorylatable Form of Phospholamban J. Biol. Chem., April 14, 2000; 275(16): 12129 - 12135. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Faraci and C. D. Sigmund Vascular Biology in Genetically Altered Mice : Smaller Vessels, Bigger Insight Circ. Res., December 3, 1999; 85(12): 1214 - 1225. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |